Related Experiment Video
Updated: Jun 2, 2026
Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina
Published on: February 13, 2021
Integrated Transcriptomics and Experimental Validation Reveal Müller Cell-Driven PANoptosis in Diabetic Retinopathy
Jing Li1, Yicong Chen2, Yunxiang Chao1
1Department of Vitreoretinal Diseases, The Affiliated Eye Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People's Republic of China.
Background:
Diabetic retinopathy (DR) is a major complication of diabetes leading to severe visual impairment. PANoptosis, a pro-inflammatory programmed cell death (PCD), has emerged as a potential pathological mechanism. This study aimed to elucidate the role of membrane protein-mediated PANoptosis in key cell populations during DR progression and to screen for coregulated genes with therapeutic potential.
Methods:
We integrated rat single-cell (scRNA-seq) and human bulk transcriptomes to identify differentially expressed PANoptosis-related genes (DE-PRGs). Single-sample gene set enrichment analysis (ssGSEA) was used to score PANoptosis activity, and CellChat was employed to examine ligand-receptor communications. Key cell subpopulations were characterized, and a protein-protein interaction (PPI) network was constructed to identify hub genes. Drug targets were predicted via the DGIDB database. Key findings were validated in a DR rat model and high-glucose-treated retinal Müller cells (RMC-1) using qRT-PCR, Western blotting, cell death assays, and siRNA-mediated PSAP knockdown.
Results:
We identified 27 DE-PRGs enriched in TNF, PCD, and p53 signaling pathways. Müller cells exhibited significantly elevated PANoptosis scores in the DR group. Intercellular communication analysis indicated that Müller cells transmit pro-apoptotic signals via the PSAP-GPR37 ligand-receptor axis. Sub-clustering identified "Müller2" as the key pathogenic subpopulation, characterized by high PSAP-GPR37 expression. Ten hub genes were screened, yielding 26 potential drug targets. Validation confirmed the downregulation of DLG4 and the upregulation of FN1, EMP3, PDGFRβ, and PSAP in DR models. In vitro, high glucose induced cell death and upregulated PANoptosis markers (NLRP3, cleaved caspase-8, and the p-MLKL/MLKL ratio). Notably, siRNA-mediated PSAP knockdown effectively attenuated the high glucose-induced elevation of these PANoptosis proteins.
Conclusion:
Integrating single-cell and bulk transcriptomics, this study suggests Müller cells-specifically the Müller2 subpopulation-as central drivers of PANoptosis in DR via PSAP-GPR37 signaling. Furthermore, the identified hub genes and PSAP provide a theoretical basis for precise, cell-subpopulation-specific intervention strategies.
